IOTA Pharmaceuticals


IOTA Pharmaceuticals
Fragment - based Drug Discovery
GBM Drug Bank
Glioma & Glioblastoma
WINDOW on Glioblastoma
IOTA Pharmaceuticals
July 14, 2017

IOTA scientist publishes book chapter on drug targeting for Protein-Protein Interactions

IOTA co-founder Dr Susan Boyd, together with collaborators from Sweden and the UK, have published a book chapter entitled “Tailoring Hit Identification and Qualification Methods for Targeting Protein–Protein Interactions” in Applied Biophysics for Drug Discovery. Access the chapter here.